Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 13/20 | 0.66 |
| ▸ | MAOA | P21397 | 5/20 | 0.66 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.66 |
| ▸ | SDHA | P31040 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | CALML3 | P27482 | 1/20 | 0.66 |
| ▸ | F10 | P00742 | 5/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12006736 | 0.88 | MAOB (0.74) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL12126891 | 0.86 | MAOB (0.65) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL15618756 | 0.86 | MAOB (0.65) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL14214166 | 0.84 | MAOB (0.70) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL12006775 | 0.84 | MAOB (0.72) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL12126903 | 0.84 | MAOB (0.72) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL12006777 | 0.84 | MAOB (0.72) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL14970856 | 0.83 | MAOB (0.72) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL15793246 | 0.82 | MAOB (0.72) | MAOBMAOAPTGS1SDHALMNA | |
| SCHEMBL2829207 | 0.82 | MAOB (0.72) | MAOBMAOAPTGS1SDHALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9376407-B2 | Process for preparation of Linezolid and its novel intermediates | LEE PHARMA LIMITED (IN) | 2016-06-28 | — | — | US | disclosed |
| US-9376407-B2 | Process for preparation of Linezolid and its novel intermediates | LEE PHARMA LIMITED (IN) | 2016-06-28 | — | — | US | disclosed |